Analyst ratings, especially from a reputable financial institution like Citigroup, can significantly influence investor sentiment and stock prices. A Buy rating combined with a substantial price target suggests a positive outlook for ArriVent BioPharma, likely leading to increased investor interest and potentially a rise in stock price in the short term.